| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77e0c210730c2b581e021b32e5c33a14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bce595c861dba361078ba893e4713be |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-085 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-7233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 |
| filingDate |
2016-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48a7e5d40285eb390cf6b01c993cbb3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac7913ea5d7257ba8d6f1bbe9bada963
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fc295567890787ff930a55d0da707e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fb54e5a98b3a2410f745b3d9e0713a9 |
| publicationDate |
2018-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018275151-A1 |
| titleOfInvention |
Metabolomic signature of diagnosis and disease progression in non-alcoholic fatty liver disease (nafld) |
| abstract |
The present invention is directed to a diagnostic method for non-alcoholic fatty liver disease (NAFLD) and to a method for monitoring the progression of the disease based on the determination of the levels of different metabolites. The invention also provides a method for determining the efficacy of an NAFLD therapy and a method for identification of compounds suitable for the treatment of NAFLD. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11740211-B2 |
| priorityDate |
2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |